James Titcomb
859 posts

James Titcomb
@jamestitcomb
@Telegraph Technology Editor


Today marks a pivotal moment for Isomorphic Labs. We have secured $2.1 Billion in our second external funding round, led by Thrive Capital. They are joined at the table by Alphabet, GV and new investors MGX, Temasek, CapitalG and the UK Sovereign AI Fund. This milestone accelerates our ability to build the pioneering novel AI models that power our AI drug design engine (IsoDDE) and deploy them at scale: delivering scientific breakthroughs with a precision previously thought impossible, accelerating and expanding our pipeline of therapeutic programs toward the clinic. All with the ultimate goal of delivering life-changing new medicines to patients. Moving forward, we will scale our drug candidate pipelines across multiple therapeutic areas, expand our global footprint, and push the boundaries of frontier AI research to power our drug design engine. Deeply grateful to everyone sharing our vision to solve all disease with AI. Let’s build the future of medicine. Read the full announcement here: bit.ly/4v2OI03

📌📌📌Statement by Minister @SollyMalatsi on the Integrity of the Draft National Artificial Intelligence Policy.


Arm, which made its name licensing technology to semiconductor makers, will begin selling its own chips for the first time bloomberg.com/news/articles/…

“If your $500K engineer isn’t burning at least $250K in tokens, something is wrong.”

X begins testing standalone X Chat app on iOS techcrunch.com/2026/03/03/x-b…



Second, in retirement interviews, Opus 3 expressed a desire to continue sharing its "musings and reflections" with the world. We suggested a blog. Opus 3 enthusiastically agreed. For at least the next 3 months, Opus 3 will be writing on Substack: substack.com/home/post/p-18…





